Filing Date |
T Date |
Ticker |
Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
#f |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
8/12/24 17:23 | 8/9/24 | GANX | Health | Drug | Pharmaceutical Preparations | Mack Gene | MD | O | CFO,Inte | 1 | P | 15 | 1.01 | 0 | 14 | 14 | D | |||||||||||||||
8/12/24 17:23 | 8/9/24 | GANX | Health | Drug | Pharmaceutical Preparations | Islam Khalid | MD | DO | Exec CB | 1 | P | 50 | 0.9988 | 0 | 50 | 6 | 931 | D | ||||||||||||||
7/1/24 17:00 | 7/1/24 | GANX | Health | Drug | Pharmaceutical Preparations | Richman Eric I | MD | D | 1 | P | 21 | 1.22 | 0 | 17 | 6 | 304 | D | |||||||||||||||
4/1/24 16:01 | 3/28/24 | GANX | Health | Drug | Pharmaceutical Preparations | Riley Jeffrey Scott | MD | D | 1 | P | 116 | 3.86 | 0 | 30 | 30 | D |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |